IP Verse

Method For Treating Primary Insomnia - EP3103443

The patent EP3103443 was granted to Neurim Pharmaceuticals on Jun 30, 2021. The application was originally filed on Aug 12, 2002 under application number EP16172415A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3103443

NEURIM PHARMACEUTICALS
Application Number
EP16172415A
Filing Date
Aug 12, 2002
Status
Granted And Under Opposition
May 28, 2021
Grant Date
Jun 30, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDMar 29, 2022MAIWALDWITHDRAWN
NEURAXPHARM ARZNEIMITTELMar 29, 2022TER MEER STEINMEISTER & PARTNERWITHDRAWN
TEVA PHARMACEUTICALSMar 29, 2022ELKINGTON AND FIFEWITHDRAWN
HAMM & WITTKOPPFeb 9, 2022HAMM & WITTKOPPADMISSIBLE
ORIFARM GENERICSSep 30, 2021ZBM PATENTS APSADMISSIBLE
GENERICS UKJun 30, 2021ELKINGTON AND FIFEWITHDRAWN

Patent Citations (34) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2789118
DESCRIPTIONUS2990401
DESCRIPTIONUS3048581
DESCRIPTIONUS3126375
DESCRIPTIONUS3749712
DESCRIPTIONUS3928326
DESCRIPTIONUS3929768
DESCRIPTIONUS3996359
DESCRIPTIONUS5151446
DESCRIPTIONUS5318994
DESCRIPTIONUS5385944
DESCRIPTIONUS5403851
DESCRIPTIONUS5498423
DESCRIPTIONUS5776969
DESCRIPTIONWO9413643
DESCRIPTIONWO9413644
DESCRIPTIONWO9413661
DESCRIPTIONWO9413676
DESCRIPTIONWO9413677
DESCRIPTIONWO9700069
OPPOSITIONEP0513702
OPPOSITIONEP0565296
OPPOSITIONEP0724878
OPPOSITIONEP1441702
OPPOSITIONEP2760523
OPPOSITIONIL103411
OPPOSITIONUS5498423
OPPOSITIONUS5707652
OPPOSITIONWO0149286
OPPOSITIONWO03015690
OTHEREP1441702
SEARCHEP0565296
SEARCHEP0724878
SEARCHWO0149286

Non-Patent Literature (NPL) Citations (110) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ELLIS, C.M. ET AL., J. SLEEP RES., (1996), vol. 5, pages 61 - 65-
DESCRIPTION- HUGHES, R.J. ET AL., SLEEP, (1998), vol. 21, pages 52 - 68-
DESCRIPTION- JAMES, S.P. ET AL., NEUROPSYCHOPHARMACOLOGY, (1990), vol. 3, pages 19 - 23-
DESCRIPTION- MACFARLANE J.G. ET AL., BIOL PSYCHIATRY, (1991), vol. 30, no. 4, pages 371 - 6-
DESCRIPTION- ROTH; THOMAS; ROEHRS, TIMOTHY SLEEP, (1996), vol. 19, no. 8, pages S48 - 49-
DESCRIPTION- VITIELLO, MICHAEL GERIATRICS, (1999), vol. 54, no. 11, pages 47 - 52-
EXAMINATION- Anonymous, "307.42 Primary insomnia", Diagnostic and statistical manual of mental disorders: DSM-IV. 4th Edition, Washington, DC, The American Psychiatric Association, (19940101), pages 22,23,553 - 557, XP055648050-
EXAMINATION- Anonymous, "Nonorganic insomnia", The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines, Nonorganic insomnia, World Health Organisation, (19920101), pages 32,182 - 183, XP055648131-
EXAMINATION- HAIMOV I ET AL, "Melatonin replacement therapy elderly insomniacs", SLEEP, ALLEN PRESS, LAWRENCE, KS, US, (19950101), vol. 18, no. 7, ISSN 0161-8105, pages 598 - 603, XP002990657-
EXAMINATION- Per Bech, "Rating scales for mental disorders: insomnia", Rating scales for psychopathology health status and quality of life: a compendium on documentation in accordance with the DSM-III-R and WHO Systems, Springer-Verlag, (19930101), pages 218 - 222, XP055648079-
EXAMINATION- ROTH T ET AL, "Consensus for the pharmacological management of insomnia in th enew millennium", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, MEDICON INTERNATIONAL, ESHER, GB, (20010101), vol. 55, no. 1, ISSN 1368-5031, page 10PAGES, XP002990688-
EXAMINATION- GARFINKEL ET AL, "Improvement of sleep quality in elderly people by controlled-release melatonin", LANCET, ELSEVIER, AMSTERDAM, NL, (19950101), vol. 346, doi:10.1016/S0140-6736(95)91382-3, ISSN 0140-6736, pages 541 - 544, XP002990656
OPPOSITION- Aili K., Et Al., "Reliability of Actigraphy and Subjective Sleep Measurements in Adults: The Design of Sleep Assessments.", JCSM, (20170101), vol. 13, no. 1, pages 39 - 47, XP055863154-
OPPOSITION- ALFONSO R. GENNAR O, "Oral dosage forms", Remington: The Science and Practice of Pharmacy, (20000101), pages 910 - 914, XP055465494-
OPPOSITION- ALFONSO R. GENNARO, "Oral dosage forms", Remington: The Science and Practice of Pharmacy, (20000101), pages 910 - 914, XP055465494-
OPPOSITION- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders fourth edition", (19940101), vol. 22, no. 23, pages 553 - 557, XP055862098-
OPPOSITION- American Psychiattric Association, "Primary Sleep Disorders", Diagnostic and Statistical Manual of Mental Disorders fourth edition, (19940000), pages 553 - 557, XP055863213-
OPPOSITION- American Psychiattric Association, "Primary Sleep Disorders", Diagnostic and Statistical Manual of Mental Disorders fourth edition, (19940101), pages 553 - 557, XP055863213-
OPPOSITION- Anonymous, "307.42 Primary insomnia", Diagnostic and statistical manual of mental disorders: DSM-IV. 4th Edition, Washington, DC , The American Psychiatric Association , (19940101), pages 22,23,553 - 557, XP055648050-
OPPOSITION- Anonymous, American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders fourth edition", (19940101), vol. 22, no. 23, pages 553 - 557, XP055862098-
OPPOSITION- ANONYMOUS, "Annex I Summary of Product Characteristics", European Medicines Agency, (20120619), pages 1 - 10, URL: http://www.ema. europa .eu/docs/en_ GB /document_librai EPAR_-_Product_Information/human/000695/ WC500026811.pdf, (20131001), XP055863149-
OPPOSITION- Anonymous, "Assesment Report for Circadin", EMEA, (20070101), pages 1 - 52, URL: http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_- _Scientific_Discussion/human/000695/WC50002680.pdf, (20180409), XP055465425-
OPPOSITION- ANONYMOUS, "Assesment Report for Circadin", European Medicines Agency, London, UK, (20070101), pages 1 - 52, URL: http://www.ema. europa .eu/docs/en_ GB /document_library/ EPAR_-_Scientific_Discussion/human/000695/ WC500026808.pdf, (20131001), XP055465425-
OPPOSITION- Anonymous, "Clinical Investigation of Hypnotic Medicinal Products", Directive 75/318/EEC, (19920000), pages 359 - 370, XP055862255-
OPPOSITION- Anonymous, "Clinical Investigation of Hypnotic Medicinal Products", Directive 75/318/EEC, (19920101), pages 359 - 370, Directive 75/318/EEC, (20211116), XP055862255-
OPPOSITION- Anonymous, "Diagnostic and Statistical Manual of Mental Disorders fourth edition", American Psychiatric Association, (19940000), vol. 22, no. 23, pages 553 - 557, XP055862098-
OPPOSITION- ANONYMOUS, Guideline on medicinal products for the treatment of insomnia, (20110217), pages 1 - 21, URL: http://www.ema. europa .eu/docs/en_ GB /document_ibrary/ Scientific_guideline/2011/02/WC500102351 .pdf, (20180409), XP055465468-
OPPOSITION- Anonymous, "Guideline on medicinal products for the treatment of insomnia", (20110217), pages 1 - 21, URL: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/02/WC500102351.pdf, (20180409), XP055465468-
OPPOSITION- Anonymous, "Guideline on medicinal products for the treatment of insomnia", EMA, (20110000), pages 1 - 21, XP055465468-
OPPOSITION- Anonymous, "The ICD -10 Classification of Mental and Behavioural disorders", Clinical descriptions and diagnostic guidelines, WHO, (19920000), pages 182 - 184, XP055863218-
OPPOSITION- Anonymous, "The ICD -10 Classification of Mental and Behavioural disorders", Clinical descriptions and diagnostic guidelines, WHO, (19920101), pages 182 - 184, Clinical descriptions and diagnostic guidelines, (20211118), XP055863218-
OPPOSITION- Anonymous, "The ICD -10 Classification of Mental and Behavioural disorders", Clinical descriptions and diagnostic guidelines, WHO, (19920101), pages 182 - 184, Clinical descriptions and diagnostic guidelines, WHO, (20211118), XP055863218-
OPPOSITION- ARIEL PABLOS-MENDEZ et al., "Run-in Periods in Randomized Trials: Implications for the Application of Results in Clinical Practice", JAMA, (19980121), vol. 279, no. 3, pages 222 - 225, XP055465467-
OPPOSITION- BECH P, "Rating scales for psychopathology health status and quality of life: a compendium on documentation in accordance with the DSM-III-R and WHO Systems", Rating scales for mental disorders: insomnia, Berlin, Heidelberg, (19930000), pages 218 - 222, XP055648079-
OPPOSITION- BRUSCO et al., "Effect of melatonin in selected populations of sleep-disturbed patients", BIOLOGICAL SIGNAL AND RECEPTORS, (19990101), vol. 8, ISSN 1422-4933, pages 126 - 131, XP002990655-
OPPOSITION- BRUSCO et al., "Effect of melatonin in selected populations of sleep-disturbed patients", BIOLOGICAL SIGNAL AND RECEPTORS, BASEL, CH, (19990101), vol. 8, ISSN 1422-4933, pages 126 - 131, XP002990655-
OPPOSITION- D56-19 of the opposition- appeal proceedings against TM1-
OPPOSITION- D56-21 of the opposition- appeal proceedings against TM1-
OPPOSITION- D56-22 of the opposition- appeal proceedings against TM1-
OPPOSITION- DAGAN Y. et al., "Sleep quality in children with attention deficit hyperactivity disorder: an actigraphic study", Psychiatry and Clinical neurosciences, (19970000), vol. 51, no. 6, pages 383 - 386, XP055878066-
OPPOSITION- Dagan Y, Et Al, "Sleep quality in children with attention deficit hyperactivity disorder: An actigraphic study", Psychiatry Clin Neurosci ., (19970101), pages 383 - 386, Psychiatry Clin Neurosci ., URL: https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1440-1819.1997.tb02604.x, (20220112), XP055878066-
OPPOSITION- DAWSON D. et al., "Improving adaptation to simulated night shift: timed exposure to bright", Sleep, (19950000), vol. 18, no. 1, pages 11 - 21, XP055465457-
OPPOSITION- Declaration by Professor Kevin Morgan and D56-KM1 to D56-KM56 (which are cited in the decaration as KM-1 to KM-56-
OPPOSITION- Declaration Prof. Roth from UK proceedings-
OPPOSITION- Diagnostic and Statistical Manual of Mental Disorders, (20130000), pages 7 - 22-
OPPOSITION- DREW DAWSON et al., "Shift Work and Sleep Deprivation - Improving Adaptation to Simulated Night Shift: Timed Exposu to Bright Light Versus Daytime Melatonin Administration", SLEEP, (19950101), vol. 18, no. 1, pages 11 - 21, XP055465457-
OPPOSITION- DREW DAWSON et al., "Shift Work and Sleep Deprivation - Improving Adaptation to Simulated Night Shift: Timed Exposu to Bright Light Versus Daytime Melatonin Administration", SLEEP, (19950101), vol. 18, pages 11 - 21, XP055465457-
OPPOSITION- DUBOCOVICH M L et al., Melatonin receptors, (19980101), vol. 1, pages 187 - 193, XP002990671-
OPPOSITION- FAINSTEIN et al., "Effects of melatonin in elderly patients with sleep disturbance: a pilot study", CURRENT THERAPEUTIC RESEARCH, (19971201), vol. 58, no. 12, pages 990 - 1000, XP002990653-
OPPOSITION- FAINSTEIN et al., "Effects of melatonin in elderly patients with sleep disturbance: a pilot study", CURRENT THERAPEUTIC RESEARCH, XX, XX, (19971201), vol. 58, no. 12, pages 990 - 1000, XP002990653-
OPPOSITION- Fda, "Circadin 2 mg prolonged-release tablets", ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS, (20120619), pages 1 - 26, ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS, URL: https://www.ema.europa.eu/en/documents/product-information/circadin-epar-product-information_en.pdf, (20220308), XP055898639-
OPPOSITION- GARFINKEL D et al., "Facilitation of BZD discontinuation by melatonin: a new clinical approach", INTERNET CITATION, (19970000), (19970101), XP002990672-
OPPOSITION- GARFINKEL D et al., "Facilitation of BZD discontinuation by melatonin: a new clinical approach", INTERNET CITATION, (19970101), XP002990672-
OPPOSITION- Guideline on medicinal products for the treatment of insomnia, (20110217), pages 1 - 21, URL: http://www.ema. europa .eu/docs/en- GB /document library/ Scientific_guideline/2011/02/WC500102351.pdf, XP055465468-
OPPOSITION- HAIMOV et al., "Sleep disorders and melatonin rhythms in elderly people", British Medical Journal, (19940000), vol. 309, page 167, XP055862264-
OPPOSITION- Haimov, Et Al., "Sleep disorders and melatonin rhythms in elderly people", British Medical Journal, (19940101), vol. 309, page 167, XP055862264-
OPPOSITION- HAIMOV I. ET AL., "Melatonin replacement therapy elderly insomniacs", SLEEP, ALLEN PRESS, LAWRENCE, KS, US, US , (19950101), vol. 18, no. 7, ISSN 0161-8105, pages 598 - 603, XP002990657-
OPPOSITION- HAIMOV I et al., "Melatonin replacement therapy of elderly insomniacs", SLEEP, LAWRENCE, KS, US, (19950101), vol. 18, no. 7, ISSN 0161-8105, pages 598 - 603, XP002990657-
OPPOSITION- HAIMOV I et al., "Potential of melatonin replacement therapy in older patients with sleep disorders", DRUGS & AGING, NZ, (19950101), vol. 7, no. 2, ISSN 1170-229X, pages 75 - 78, XP002990660-
OPPOSITION- HAIMOV I., LAVIE P., "Potential of melatonin replacement therapy in older patients with sleep disorders", Drugs & Aging, Adis International Ltd., AUCKLAND,NEW ZENLAND, AUCKLAND,NEW ZENLAND , (19950101), vol. 7, no. 2, ISSN 1170-229X, pages 75 - 78, XP002990660-
OPPOSITION- Hauri Peter J, "Insomnia", Sleep disorders, (19980301), vol. 19, no. 1, pages 157 - 168, XP055910237-
OPPOSITION- Horne J A, Pankhurst F L, Reyner L A, Hume Tk, Diamond I D, "A Field Study of Sleep Disturbance: Effects of Aircraft Noise and Other Factors on 5,742 Nights of Actimetrically Monitored Sleep in a Large Subject Sample", American Sleep Disorders Association and Sleep Research Society, (19940101), vol. 17, pages 146 - 159, XP055863565-
OPPOSITION- Horne J A, Pankhurst F L, Reyner L A, Hume Tk, Diamond I D, "A Field Study of Sleep Disturbance: Effects of Aircraft Noise and Other Factors on 5,742 Nights of Actimetrically Monitored Sleep in a Large Subject Sample", Sleep, (19940000), vol. 17, no. 2, pages 146 - 159, XP055863565-
OPPOSITION- HUGHES R J et al., "T he role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement", SLEEP, LAWRENCE, KS, US, (19980101), vol. 21, no. 1, ISSN 0161-8105, pages 52 - 68, XP002990675-
OPPOSITION- HUGHES R J et al., "The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement", SLEEP, LAWRENCE, KS, US, (19980101), vol. 21, no. 1, ISSN 0161-8105, pages 52 - 68, XP002990675-
OPPOSITION- I. HAIMOV et al., "Melatonin Replacement Therapy of Elderly Insomniacs", Sleep, (19950000), vol. 18, no. 7, pages 598 - 603, XP002990657-
OPPOSITION- I. HAIMOV et al., "Potential of Melatonin Replacement Therapy in Older Patients with Sleep Disorders", Drugs & Aging, (19950000), vol. 7, pages 75 - 78, XP002990660-
OPPOSITION- J.A. HOME et al., Sleep, (19940000), vol. 17, no. 2, pages 146 - 159, XP055863565-
OPPOSITION- K. AILI et al., "Reliability of Actigraphy and Subjective Sleep Measurements in Adults: The Design of Sleep Assessments.", JCSM, (20170000), vol. 13, no. 1, pages 39 - 47, XP055863154-
OPPOSITION- LEMOINE PATRICK et al., "Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects", JOURNAL OF SLEEP RESEARCH, (20071200), vol. 16, no. 4, ISSN 0962-1105, pages 372 - 380, XP055465436-
OPPOSITION- MELATONEX extract from WEBARCHIVE-
OPPOSITION- MICHAEL E. AULTON, Pharmaceutics: The science of dosage form design (passage, (19880101), XP055465490-
OPPOSITION- MICHAEL E. AULTON, "Pharmaceutics: The science of dosage form design (passage", Pharmaceutics: The science of dosage form design, (19880101), pages 315 - 317, XP055465490-
OPPOSITION- Morgan K., Et Al., "The assessment of sleep", Sleep Management in Nursing Practice, (19990101), pages 69 - 75, Sleep Management in Nursing Practice, (20211116), XP055862239-
OPPOSITION- Per Bech, "Rating scales for mental disorders: insomnia", Rating scales for psychopathology health status and quality of life: a compendium on documentation in accordance with the DSM-III-R and WHO Systems, Springer-Verlag , (19930101), pages 218 - 222, XP055648079-
OPPOSITION- ROTH T et al., "Consensus for the pharmacological management of insomnia in the new millennium", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, MEDICON INTERNATIONAL, (20010101), vol. 55, no. 1, ISSN 1368-5031, XP002990688-
OPPOSITION- ROTH T et al., "Consensus for the pharmacological management of insomnia in the new millennium", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, MEDICON INTERNATIONAL, ESHER, GB, (20010101), vol. 55, no. 1, ISSN 1368-5031, page 10, XP002990688-
OPPOSITION- ROTH T. ET AL., "Consensus for the pharmacological management of insomnia in the new millennium", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, MEDICON INTERNATIONAL, ESHER, GB, GB , (20010101), vol. 55, no. 1, ISSN 1368-5031, page 10 PAGES, XP002990688-
OPPOSITION- SADEH A. et al., "Actigraphic Home-monitoring Sleep-Disturbed and Control Infants and Young Children: A New Method for Pediatric Assessment of Sleep-Wake Patterns", Pediatrics, (19910000), vol. 87, no. 4, pages 494 - 9, XP055878061-
OPPOSITION- Sadeh A, Et Al, "Actigraphic home-monitoring sleep-disturbed and control infants and young children : a new method for pediatric assessment of sleep-wake patterns", Pediatrics (Evanston), American Academy of Pediatrics, Elk Grove Village, IL, Elk Grove Village, IL, (19910101), pages 494 - 499, Pediatrics (Evanston), URL: https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.454.6715&rep=rep1&type=pdf, (20220112), XP055878061-
OPPOSITION- SILVA J A C E et al., "Special report from a symposium held by the WHO and the World Federation of sleep research societies: an overview of insomnias and related disorders - recognition, epidemiology and rational management", SLEEP, LAWRENCE, KS, US, (19960101), vol. 19, no. 5, ISSN 0161-8105, pages 412 - 416, XP002990669-
OPPOSITION- "Sleep Management in Nursing Practice", Morgan K., Et Al., The assessment of sleep, (19990000), pages 69 - 75, XP055862239-
OPPOSITION- ZHDANOVA I V et al., "Melatonin: a sleep-promoting hormone", SLEEP, (19970101), vol. 20, no. 1 0, ISSN 0161-8105, pages 899 - 907, XP002990662-
OPPOSITION- ZHDANOVA I V et al., "Melatonin: a sleep-promoting hormone", SLEEP, LAWRENCE, KS, US, (19970101), vol. 20, no. 10, ISSN 0161-8105, pages 899 - 907, XP002990662-
OPPOSITION- ZOMER et al., "Mini Seep Questionnaire (MSQ) for Screening Large Populations for EDS Complaints", J. Methods, (19850000), pages 467 - 470, XP055862273-
OPPOSITION- Zomer, Et Al., "Mini Seep Questionnaire (MSQ) for Screening Large Populations for EDS Complaints", J. Methods, (19850101), pages 467 - 470, J. Methods, (20211116), XP055862273-
OPPOSITION- DAVID CHAVALARIAS et al., "Evolution of Reporting P Values in the Biomedical Literature, 1990-2015", JAMA THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, (20160315), vol. 315, no. 11, pages 1141 - 1148, XP055465485
OPPOSITION- DAVID CHAVALARIAS et al., "Evolution of Reporting P Values in the Biomedical Literature, 1990-2015", JAMA THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, US, (20160315), vol. 315, no. 11, ISSN 0098-7484, pages 1141 - 1148, XP055465485
OPPOSITION- Zisapel Nava, "Development of a melatonin-based formulation for the treatment of insomnia in the elderly", DRUG DEVELOPMENT RESEARCH., NEW YORK, NY, US, US , (20000701), vol. 50, no. 3-4, doi:10.1002/1098-2299(200007/08)50:3/4<226::AID-DDR6>3.0.CO;2-S, ISSN 0272-4391, pages 226 - 234, XP055912661
OPPOSITION- Faerman Afik, Kaplan Katherine A., Zeitzer Jamie M., "Subjective sleep quality is poorly associated with actigraphy and heart rate measures in community-dwelling older men", Sleep Medicine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20200901), vol. 73, doi:10.1016/j.sleep.2020.04.012, ISSN 1389-9457, pages 154 - 161, XP055878076
OPPOSITION- GARFINKEL et al., "Improvement of sleep quality in elderly people by controlled-release melatonin", LANCET, AMSTERDAM, NL, (19950101), vol. 346, ISSN 0140-6736, pages 541 - 544, XP002990656
OPPOSITION- GARFINKEL et al., "Improvement of sleep quality in elderly people by controlled-release melatonin", LANCET, AMSTERDAM, NL, (19950101), vol. 346, pages 541 - 544, XP002990656
OPPOSITION- MONTI J M et al., "Polysomnographic study of the effect of melatonin on sleep in elderly patients with chronic primary insomnia", ARCHIVES OF GERONTOLOGY AND GERIATRICS, AMSTERDAM, NL, (19990101), vol. 28, ISSN 0167-4943, pages 85 - 98, XP002990661
OPPOSITION- Haimov Iris, "Melatonin Rhythm Abnormalities and Sleep Disorders in the Elderly", CNS SPECTRUMS, MBL COMMUNICATIONS, NEW YORK, NY, US, US , (20010601), vol. 6, no. 6, doi:10.1017/S109285290000804X, ISSN 1092-8529, pages 502 - 506, XP055912666
OPPOSITION- UCHIKAWA O et al., "Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists", JOURNAL OF MEDICINAL CHEMISTRY, WASHINGTON, US, (20020101), vol. 45, ISSN 0022-2623, pages 4222 - 4239, XP002990691
OPPOSITION- PERLIS M L et al., "Psychophysiological insomnia: the behavioural model and a neurocognitive perspective", JOURNAL OF SLEEP RESEARCH, OXFORD, GB, (19970101), vol. 6, ISSN 0962-1105, pages 179 - 188, XP002990686
OPPOSITION- PERLIS ML et al., "Psychophysiological insomnia: the behavioural model and a neurocognitive perspective", JOURNAL OF SLEEP RESEARCH, OXFORD, GB, (19970101), vol. 6, pages 179 - 188, XP002990686
OPPOSITION- Ohayon Maurice M; Caulet Malijai; Guilleminault Christian, "How a general population perceives its sleep and how this relates to the complaint of insomnia", AMERICAN SLEEP DISORDERS ASSOCIATION AND SLEEP RESEARCH SOCIETY, vol. 20, no. 9, pages 715 - 723, XP055797494
OPPOSITION- Arendt J, "In what circumstances is melatonin a useful sleep therapy? Consensus statement, WFSRS Focus Group, Dresden, November 1999", JOURNAL OF SLEEP RESEARCH, BLACKWELL SCIENTIFIC, OXFORD,, GB, GB , (20001218), vol. 9, no. 4, doi:10.1111/j.1365-2869.2000.00229.x, ISSN 0962-1105, pages 397 - 398, XP055898679
OPPOSITION- HAJAK et al., "Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia", J Pineal Res, (19950000), vol. 19, doi:10.1111/j.1600-079X.1995.tb00179.x, pages 116 - 122, XP055878071
OPPOSITION- Hajak Göran, Et Al, "Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia", JOURNAL OF PINEAL RESEARCH, MUNKSGAARD, COPENHAGEN, DK, DK , (19951001), vol. 19, no. 3, doi:10.1111/j.1600-079X.1995.tb00179.x, ISSN 0742-3098, pages 116 - 122, XP055878071
OPPOSITION- BUBENIK G A et al., "PROSPECTS OF THE CLINICAL UTILIZATION OF MELATONIN", BIOLOGICAL SIGNAL AND RECEPTORS, (19980101), vol. 7, no. 4, ISSN 1422-4933, pages 195 - 219, XP000893109
OPPOSITION- BUBENIK G A et al., "PROSPECTS OF THE CLINICAL UTILIZATION OF MELATONIN", BIOLOGICAL SIGNAL AND RECEPTORS, BASEL, CH, (19980101), vol. 7, no. 4, ISSN 1422-4933, pages 195 - 219, XP000893109
OPPOSITION- ZISAPEL et al., "The use of melatonin fo rth etreatment of insomnia", BIOLOGICAL SIGNAL AND RECEPTORS, (19990101), vol. 8, ISSN 1422-4933, pages 84 - 89, XP002990654
OPPOSITION- ZISAPEL et al., "The use of melatonin fo rth etreatment of insomnia", BIOLOGICAL SIGNAL AND RECEPTORS, KARGER, BASE !, CH, (19990101), vol. 8, ISSN 1422-4933, pages 84 - 89, XP002990654
OPPOSITION- BUYSSE DJ et al., "Diagnostic concordance for DSM-IV sleep disorders: a report from the APA/NIMH DSM-IV field trial", AMERICAN JOURNAL OF PSYCHIATRY, (19940901), vol. 151, no. 9, ISSN 0002-953X, pages 1351 - 1360, XP008152789
OPPOSITION- BUYSSE D J et al., "Diagnostic concordance for DSM-IV sleep disorders: a report from the APA/NIMH DSM-IV field trial", AMERICAN JOURNAL OF PSYCHIATRY, US, (19940901), vol. 151, no. 9, ISSN 0002-953X, pages 1351 - 1360, XP008152789
OTHER- OHAYON M. M. et al., "How a General Population Perceives Its Sleep and How This Relates to the Complaint of Insomnia", Sleep, (19970901), vol. 20, no. 9, pages 715 - 723, XP055797494
SEARCH- BRUSCO ET AL, "Effect of melatonin in selected populations of sleep-disturbed patients", BIOLOGICAL SIGNAL AND RECEPTORS, KARGER, BASEL, CH, (19990101), vol. 8, ISSN 1422-4933, pages 126 - 131, XP002990655 [X] 1-2,4-5 * page 127, column l - column r, paragraph 2 * [Y] 3,6-
SEARCH- FAINSTEIN ET AL, "Effects of melatonin in elderly patients with sleep disturbance: a pilot study", CURRENT THERAPEUTIC RESEARCH, XX, XX, (19971201), vol. 58, no. 12, pages 990 - 1000, XP002990653 [X] 1-2,4-5 * page 992, paragraph 2 - page 993, paragraph l; table 1 * * page 994, paragraph 5 - page 995, paragraph 1 * * page 997, paragraphs 1,2; figure 3 * * page 998; figure 4 * [Y] 3,6-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents